Recent advances in anticancer approach of traditional medicinal plants: A novel strategy for cancer chemotherapy

Abstract

Background: Cancer is the second leading cause of death worldwide. Although great advancements have been made in the treatment and control of cancer progression, significant deficiencies and room for improvement remain. Several undesired side effects sometimes occur during chemotherapy. Natural therapies, such as the use of plant-derived products in cancer treatment, may reduce adverse side effects.

Methods: Currently, a few plant products are being used to treat cancer. However, a myriad of plant products exist that have shown very promising anti-cancer properties in vitro but have yet to be evaluated in humans. Further study is required to determine the efficacy of these plant products in treating cancers in humans.

Results: This review will focus on the various traditional medicinal plants and their chemical compounds that have, in recent years, shown promise as anticancer agents and will outline their potential mechanism of action.

Conclusions: The current manuscript discusses natural products currently in clinical use, and under clinical trials, for cancer chemotherapy and chemoprevention. Future research focusing on natural anticancer agents can open a new horizon in cancer treatment, which will play a great role in enhancing the survival rate of cancer patients.

Keywords

Medicinal plants / Novel agents / Phytoconstituents / Anticancer / Antioxidant / Apoptosis / Remedies / Review

References

[1] World Health Organization. WHO Global report. Preventing Chronic Diseases: A Vital Investment. vol. 35. Geneva: WHO press;2005:1107, 4(1).

[2] Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):442.

[3] Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757.

[4] Hoyert DL, Heron MP, Murphy SL, et al. Healthcare disparities at the crossroad with healthcare reform. Vital Stat Rep. 2006;54(13):1–120.

[5] Sener SF, Grey N. The global burden of cancer. J Surg Oncol. 2005;92(1):1–3.

[6] Parkin DM. The global burden of cancer. Oncogene. 2004;23(38):6329–6340.

[7] Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153–156.

[8] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA: Cancer J Clin. 2007;57(1):43–66.

[9] Macdonald JS. Toxicity of 5-fluorouracil. Oncology. 1999;13(7 Suppl 3):33–34.

[10] Rexroth G, Scotland V. Cardiac toxicity of 5-fluorouracil. Med Klin. 1994;89(12):680–688.

[11] Rastogi N, Chag M, Ayyagari S. Myocardial ischemia after 5-fluorouracil chemotherapy. Int J Cardiol. 1993;42(3):285–287.

[12] Aviles A, Arevila N, Diaz Maqueo JC, Gomez T, Garcia R, Nambo MJ. Leuk Lymphoma. 1993;11(3–4):275–279.

[13] Leo E, Arletti R, Forni F, et al. General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles, 52(6–7). 1997:385–388.

[14] Kilickap S, Akgul E, Aksoy S, et al. Doxorubicin-induced second degree and complete atrioventricular block. Europace. 2005;7(3):227–230.

[15] Manil L, Couvreur P, Mahieu P. Acute renal toxicity of doxorubicin (Adriamycin)-Loaded cyanoacrylate nanoparticles. Pharm Res. 1995;12(1):85–87.

[16] Gibaud S, Andreux JP, Weingarten C, et al. Increased bone marrow toxicity of doxorubicin bound to nanoparticles. Eur J Cancer. 1994;30A(6):820–826.

[17] Adamson IY. Pulmonary toxicity of bleomycin. Environ Health Perspect. 1976;16:119–125.

[18] Parvinen LM, Kilkku P, Makinen E, et al. Factors affecting the pulmonary toxicity of bleomycin. Acta Radiol Oncol. 1983;22(6):417–421.

[19] Karam H, Hurbain-Kosmath I, Housset B. Direct toxic effect of bleomycin on alveolar type 2 cells. Toxicol Lett. 1995;76(2):155–163.

[20] Cohen IS, Mosher MB, O’Keefe EJ, et al. Cutaneous toxicity of bleomycin therapy. Arch Dermatol. 1973;107(4):553–555.

[21] Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs. 1991;42(5):781–795.

[22] Taneja SC, Qazi GN. Bioactive Molecues in Medicinal Plants: a perspective in their therapeutic action. In: Drug Discovery and Development. Chorghade MS. John Wiley and Sons;2007:1–50.

[23] Rajeswara Rao BR, Singh K, Sastry KP, et al. Cultivation technology for economicaly important medicinal plants. In: Reddy KJ, Bahadur B, Bhadraiah B, Rao MLN, eds. Advances in Medicinal Plants. Hyderabad: University Press;2007:112–122.

[24] Narayan C, Kumar A. Antineoplastic and immunomodulatory effect of polyphenolic components of Achyranthes aspera (PCA) extract on urethane induced lung cancer in-vivo. Mol Biol Rep. 2014;4:179–191.

[25] Lau BHS, Tadi PP. Tosk JM Allium sativum (Garlic) and cancer prevention. Nutr Res. 1990;10(8):937–948.

[26] Kumar RA, Sridevi K, Kumar NV, et al. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol. 2004;92(2–3):291–295.

[27] Lali Growther anticancer activity of Annona muricata leaf extracts and screening for bioactive phytochemicals. Int J Pharm Biol Sci. 2018;8(1):475–481.

[28] Kviecinski MR, Benelli P, Felipe KB, et al. SFE from Bidens pilosa Linné to obtain extracts rich in cytotoxic polyacetylenes with antitumor activity. J Supercrit Fluids. 2011;56(3):243–248.

[29] Cheng G, Zhang Y, Zhang X, et al. Tubeimoside V (1), a new cyclic bisdesmoside from tubers of Bolbostemma paniculatum, functions by inducing apoptosis in human glioblastoma U87MG cells. Bioorg Med Chem Lett. 2006;16(17):4575–4580.

[30] Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;402:16–31.

[31] Romano B, Borrelli F, Pagano E, Cascio MG, Pertwee RG, Izzo AA. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine. 2014;21(5):631–639.

[32] Wang J, Ito H, Shimura K. Enhancing effect of antitumor polysaccharide from Astralagus or Radix hedysarum on C3 cleavage production of macrophages in mice. Jpn J Pharmacol. 1991;86(2):159.

[33] Ghantous A, Tayyoun AA, Lteif GA, et al. Purified salograviolide A isolated from Centaurea ainetensis causes growth inhibition and apoptosis in neoplastic epidermal cells. Internet J Oncol. 2008;32(4):841.

[34] Wang Y, Ren N, Rankin GO, et al. Anti-proliferative effect and cell cycle arrest induced by saponins extracted from tea (Camellia sinensis) flower in human ovarian cancer cells. J Funct Foods. 2017;37:310–321.

[35] Martarelli D, Martarelli B, Pediconi D, Nabissi M, Perfumi M, Pompei P. Hypericum perforatum methanolic extract inhibits growth of human prostatic carcinoma cell line orthotopically implanted in nude mice. Cancer Lett. 2004;210(1):27–33.

[36] Kupchan S, Baxter R. Mezerein: antileukemic principle isolated from Daphne mezereum L. Science. 1975;187(4177):652–653.

[37] Prakash O, Kumar A, Kumar P, Ajeet. Anticancer potential of plants and natural products: a review. Am J Pharmacol Sci. 2013;1(6):104–115.

[38] Vimalraj S, Ashokkumar T, Saravanan S. Biogenic gold nanoparticles synthesis mediated by Mangifera indica seed aqueous extracts exhibits antibacterial, anticancer and anti-angiogenic properties. Biomed Pharmacother. 2018;105:440–448.

[39] Zhen HS, Zhou YY, Yuan YF, Zhong ZG, Liang CY, Qiu Q. Study on anticancer effect in-vivo of active fraction from Nervilia fordii. J Chin Med Mater. 2007;30(9):1095–1098.

[40] Kumar DR Naveen, George V Cijo, Suresh PK, Kumar R Ashok. Cytotoxicity, apoptosis induction and anti-metastatic potential of Oroxylum indicum in human breast cancer cells. Asian Pac J Cancer Prev APJCP. 2012;13(6):2729–2734.

[41] Wang X, Gao A, Jiao Y, Zhao Y, Yang X. Antitumor effect and molecular mechanism of antioxidant polysaccharides from Salvia miltiorrhiza Bunge in human colorectal carcinoma LoVo cells. J Biol Macromol. 2018;108:625–634.

[42] Eghbali Feriz S, Taleghani A, Tayarani-Najaran Z. Scutellaria. Debates on the anticancer property. Biomed Pharmacother. 2018;105:1299–10.

[43] Joy K, Rajeshkumar N, Kuttan G, Kuttan R. Effect of Picrorrhiza kurroa extract on transplanted tumours and chemical carcinogenesis in mice. J Ethnopharmacol. 2000;71(1–2):261–266.

[44] Chen XQ, Zhao SM, Wang Z, et al. New cyclopeptides from Rubia cordifolia with cytotoxicity and inhibiting NF-κB signaling pathway. Tetrahedron. 2015;71(52):9673–9678.

[45] Brandon-Warner E, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Lett. 2012;326(1):88–95.

[46] Li YL, Gan GP, Zhang HZ, et al. A flavonoid glycoside isolated from Smilax China L. rhizome in-vitro anticancer effects on human cancer cell lines. J Ethnopharmacol. 2007;113(1):115–124.

[47] Setty Balakrishnan A, Nathan AA, Kumar M, Ramamoorthy S, Ramia Mothilal SK. Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression. Prostate Int. 2017;5(2):75–83.

[48] Prakash O, Usmani S, Singh R, Debarshi KM, Gupta A. Cancer chemotherapy by novel bio-active natural products: looking towards the future. Curr Cancer Ther Rev. 2019;15:37.

[49] Koo HN, Hong SH, Song BK, Kim CH, Yoo YH, Kim HM. Taraxacum officinale induces cytotoxicity through TNF-α and IL-1α secretion in Hep G2 cells. Life Sci. 2004;74(9):1149–1157.

[50] Saleem A, Husheem M, Härkönen P, Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol. 2002;81(3):327–336.

[51] R Haniadka, Rajeev AG, Palatty PL, Arora R, Baliga MS. Zingiber officinale (ginger) as an anti-emetic in cancer chemotherapy: a review. J Alternative Compl Med. 2012;18(5):440–444.

[52] Johnson W, Tchounwou PB, Yedjou CG. Therapeutic mechanisms of Vernonia amygdalina delile in the treatment of prostate cancer. Molecules. 2017;22(10):1594.

[53] Allsopp P, Possemiers S, Campbell D, Oyarzábal IS, Gill C, Rowland I. An exploratory study into the putative prebiotic activity of fructans isolated from Agave angustifolia and the associated anticancer activity. Anaerobe. 2013;22:38–44.

[54] Koshiura R, Miyamoto K, Ikeya Y, Taguchi H. Antitumor activity of methanol extract from roots of Agrimonia pilosa LEDEB. Jpn J Pharmacol. 1985;38:9–16.

[55] Jeong M, Kim HM, Ahn JH, Lee KT, Jang DS, Choi JH. 9-Hydroxycanthin-6-one isolated from stem bark of Ailanthus altissima induces ovarian cancer cell apoptosis and inhibits the activation of tumor-associated macrophages. Chem Biol Interact. 2018;280:99–108.

[56] Baradwaj RG, Rao MV, Senthil Kumar T. Novel purification of 1’S-1’-Acetoxychavicol acetate from Alpinia galanga and its cytotoxic plus antiproliferative activity in colorectal adenocarcinoma cell line SW480. Biomed Pharmacother. 2017;91:485–493.

[57] Numata M, Yamamoto A, Moribayashi A, Yamada H. Antitumor components isolated from the Chinese herbal medicine Coix lachryma-jobi. Planta Med. 1994;60(4):356–359.

[58] Chang SH, Bae JH, Hong DP, et al. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells. J Ethnopharmacol. 2010;130(2):248–254.

[59] Ko W, Kang T, Lee S, et al. Polymethoxyflavonoids from Vitex rotundifolia inhibit proliferation by inducing apoptosis in human myeloid leukemia cells. Food Chem Toxicol. 2000;38(10):861–865.

[60] Al-Menhali A, Al-Rumaihi A, Al-Mohammed H, et al. Thymus vulgaris (Thyme) inhibits proliferation, adhesion, migration, and invasion of human colorectal cancer cells. J Med Food. 2015;18(1):54–59.

[61] Biswas R, Mandal SK, Dutta S, Bhattacharyya SS, Boujedaini N, Khuda-Bukhsh AR. Thujone-rich fraction ofThuja occidentalisDemonstrates major anti-cancer potentials: evidences from in-vitro studies on A375 cells. Evid base Compl Alternative Med. 2011;1–16.

[62] Abdulreza AL, Mostafa RT, Seyed AM, Mansoureh B, Seyed HM, Mo Bagher R. Study of anti-cancer property of Scrophularia striata extract on the human astrocytoma cell line(1321). Iran J Pharm Res (IJPR). 2010;9(4):403–410.

[63] Huang YW, Chuang CY, Hsieh YS, et al. Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway. Environ Toxicol. 2016;32(3):1037–1046.

[64] Shenouda NS, Sakla MS, Newton LG, et al. Phytosterol Pygeum africanum regulates prostate cancer in-vitro and in-vivo. Endocrine. 2007 Feb;31(1):72–81.

[65] Tandrasasmita OM, Lee JS, Baek SH, Tjandrawinata RR. Induction of cellular apoptosis in human breast cancer by DLBS1425, a Phaleria macrocarpa compound extract, via down-regulation of PI3-kinase/AKT pathway. Cancer Biol Ther. 2010;10(8):814–823.

[66] De Marino S, Festa C, Zollo F, et al. Antioxidant activity and chemical components as potential anticancer agents in the olive leaf (Olea europaea L. cv Leccino.) decoction. Anti Cancer Agents Med Chem. 2014;14(10):1376–1385.

[67] Park C, Lee WS, Han MH, et al. Lonicera japonica Thunb. Induces caspase-dependent apoptosis through death receptors and suppression of AKT in U937 human leukemic cells. Phytother Res. 2018;32(3):504–513.

[68] Ramkumar R, Balasubramani G, Raja RK, et al. Lantana camara Linn root extract-mediated gold nanoparticles and their in-vitro antioxidant and cytotoxic potentials. Artif Cells, Nanomed Biotechnol. 2017 Jun;45(4):748–757.

[69] Chang IS, Sy LK, Cao B, et al. Shotgun proteomics and quantitative pathway analysis of the mechanisms of action of dehydroeffusol, a bioactive phytochemical with anticancer activity from Juncus effusus. J Proteome Res. 2018;17(7):2470–2479.

[70] Karmakar SR, Biswas SJ, Khuda-Bukhsh AR. Anti-carcinogenic potentials of a plant extract (Hydrastis canadensis): I. Evidence from in-vivo studies in mice (Mus musculus). Asian Pac J Cancer Prev APJCP. 2010;11(2):545–551.

RIGHTS & PERMISSIONS

2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.